Sur vs Syrian Arab Republic: HIV-positive TB patients on ART (antiretroviral therapy)
Sur
82.0%
in 2024
Syrian Arab Republic
100.0%
in 2021
Sur rank
2nd
Syrian Arab Republic rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sur
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Syrian Arab Republic's figure about 1.2 times Sur's.
Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.
Sur ranks 2nd and Syrian Arab Republic ranks 1st of 2 regions.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sur | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69.0% | 100.0% | 31.0% | Syrian Arab Republic |
| 2020s | 76.0% | 100.0% | 24.0% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sur or Syrian Arab Republic?
- Syrian Arab Republic, at 100.0% against 82.0% in Sur as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sur and Syrian Arab Republic?
- 18.0%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Sur and Syrian Arab Republic?
- 10 years are reported by both, from 2011 to 2021.
- How do Sur and Syrian Arab Republic rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sur ranks 2nd and Syrian Arab Republic ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.